Intertumoral Heterogeneity within Medulloblastoma Subgroups

Cavalli, Florence M.G., Remke, Marc, Rampasek, Ladislav, Peacock, John, Shih, David J.H., Luu, Betty, Garzia, Livia, Torchia, Jonathon +87 more·2017·Cancer Cell

Cited by (1,000)

Items 401–500 of 1,000

  1. Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses
    Konstantin Okonechnikov, Aniello Federico, Daniel Schrimpf, Philipp Sievers, Felix Sahm, Jan Köster, David Jones, Andreas von Deimling, Stefan Michael Pfister, Marcel Kool et al. · 2023 · Acta Neuropathologica Communications
  2. New insights from the widening homogeneity perspective to target intratumor heterogeneity
    Mengying Tong, Ziqian Deng, Xiaolong Zhang, Bin He, Meng‐Ying Yang, Wei Cheng, Quentin Liu · 2018 · 癌症:英文版
  3. Targeting mTOR as a Therapeutic Approach in Medulloblastoma
    Juncal Aldaregia, Ainitze Odriozola, Ander Matheu, Idoia García · 2018 · International Journal of Molecular Sciences
  4. Clinical and pre-clinical utility of genomics in medulloblastoma
    Carolina Nör, Vijay Ramaswamy · 2018 · Expert Review of Neurotherapeutics
  5. Organoids as a new approach for improving pediatric cancer research
    Silvia Lampis, Angela Galardi, Virginia Di Paolo, Angela Di Giannatale · 2024 · Frontiers in Oncology
  6. Mechanistic insights into medulloblastoma relapse
    Kendell D. Peterson, María Turos‐Cabal, April Salvador, Isabel Palomo-Caturla, Ashley J. Howell, Megan E. Vieira, Sean M. Greiner, Thibaut Barnoud, Jezabel Rodríguez‐Blanco · 2024 · Pharmacology & Therapeutics
  7. Advances on Epigenetic Drugs for Pediatric Brain Tumors
    Panagiotis Skouras, Mariam Markouli, Dimitrios Strepkos, Christina Piperi · 2022 · Current Neuropharmacology
  8. IGFBP2 promotes proliferation and cell migration through STAT3 signaling in Sonic hedgehog medulloblastoma
    Haritha Kunhiraman, Leon McSwain, Shubin Shahab, Timothy R. Gershon, Tobey J. MacDonald, Anna Marie Kenney · 2023 · Acta Neuropathologica Communications
  9. MYC up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastoma
    Consuelo Pitolli, Alberto Marini, Marika Guerra, Marco Pieraccioli, Veronica Marabitti, Fernando Palluzzi, Luciano Giacò, Gianpiero Tamburrini, Francesco Cecconi, Francesca Nazio et al. · 2023 · Journal of Experimental & Clinical Cancer Research
  10. Opportunities and Advances in Radiomics and Radiogenomics for Pediatric Medulloblastoma Tumors
    Marwa Ismail, Stephen Craig, Raheel Ahmed, Peter M K de Blank, Pallavi Tiwari · 2023 · Diagnostics
  11. The identification of BCL-XL and MCL-1 as key anti-apoptotic proteins in medulloblastoma that mediate distinct roles in chemotherapy resistance
    Marie-Claire Fitzgerald, Philip J. O’Halloran, Sean A. Kerrane, Tríona Ní Chonghaile, Niamh M. C. Connolly, Brona M. Murphy · 2023 · Cell Death and Disease
  12. Overcoming Treatment Resistance in Medulloblastoma: Underlying Mechanisms and Potential Strategies
    Hasan Slika, Aanya Shahani, Riddhpreet Wahi, Jackson Miller, Mari L. Groves, Betty Tyler · 2024 · Cancers
  13. Spatio-temporal transcriptomics of chromothriptic SHH-medulloblastoma identifies multiple genetic clones that resist treatment and drive relapse
    Ilia Kats, Milena Simovic-Lorenz, Hannah Sophia Schreiber, Pooja Sant, Jan‐Philipp Mallm, Verena Körber, Albert Li, Pravin Velmurugan, Sophie Heuer, Luisa Kües et al. · 2024 · Nature Communications
  14. Childhood Medulloblastoma Revisited
    Guilherme de Souza e Cassia, Cesar Alves, Ajay Taranath, Nicolás Sgarbi, Özgür Öztekin, Fabrício Guimarães Gonçalves, Zoltan J Patay · 2018 · Topics in Magnetic Resonance Imaging
  15. Leukotriene Synthesis Is Critical for Medulloblastoma Progression
    Fang Du, Larra W. Yuelling, Eric H. Lee, Yuan Wang, Shengyou Liao, Yan Fen Cheng, Li Zhang, Chaonan Zheng, Suraj Peri, Kathy Qi Cai et al. · 2019 · Clinical Cancer Research
  16. An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma
    Morgane Morabito, Magalie Larcher, Florence M.G. Cavalli, Chloé Foray, Antoine Forget, Liliana Mirabal-Ortega, Mamy Jean De Dieu Andrianteranagna, Sabine Druillennec, Alexandra Garancher, Julien Masliah‐Planchon et al. · 2019 · EMBO Molecular Medicine
  17. The Non-coding Side of Medulloblastoma
    Pietro Laneve, Elisa Caffarelli · 2020 · Frontiers in Cell and Developmental Biology
  18. Downregulation of miR‐326 and its host gene β‐arrestin1 induces pro‐survival activity of E2F1 and promotes medulloblastoma growth
    Evelina Miele, Agnese Pò, Angela Mastronuzzi, Andrea Carai, Zein Mersini Besharat, Natalia Pediconi, Luana Abballe, Giuseppina Catanzaro, Claudia Sabato, Enrico De Smaele et al. · 2020 · Molecular Oncology
  19. Strategies to Enhance the Efficacy of T-Cell Therapy for Central Nervous System Tumors
    Deepak Upreti, David Bakhshinyan, Darin Bloemberg, Parvez Vora, Chitra Venugopal, Sheila Kumari Singh · 2020 · Frontiers in Immunology
  20. Classifying Medulloblastoma Subgroups Based on Small, Clinically Achievable Gene Sets
    Sivan Gershanov, Shreyas Madiwale, Galina Feinberg‐Gorenshtein, Igor Vainer, Tamar Nehushtan, Shalom D. Michowiz, Nitza Goldenberg‐Cohen, Yehudit Birger, Helen Toledano, Mali Salmon‐Divon · 2021 · Frontiers in Oncology
  21. Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience
    Nazanin Majd, Max Mastall, Heather Yan Lin, Seyedeh S. Dibaj, Kenneth R. Hess, Ying Yuan, Manuela Martín-Bejarano García, Gregory N. Fuller, Kristin D Alfaro, Maria Kristine Gule-Monroe et al. · 2021 · Neuro-Oncology Advances
  22. Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma
    Veronica Marabitti, Manuela Giansanti, Francesca De Mitri, Francesca Gatto, Angela Mastronuzzi, Francesca Nazio · 2022 · Frontiers in Cell and Developmental Biology
  23. Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature
    Louisa Taylor, Philippa Wade, James E. C. Johnson, Macha Aldighieri, Sonia Morlando, Gianpiero Di Leva, Ian Derek Kerr, Beth Coyle · 2023 · Cancers
  24. Arsenic Trioxide exerts cytotoxic and radiosensitizing effects in pediatric Medulloblastoma cell lines of SHH Subgroup
    Paulo Henrique dos Santos Klinger, Lara Elis Alberici Delsin, Gustavo Alencastro Veiga Cruzeiro, Augusto Faria Andrade, Régia Caroline Peixoto Lira, Pamela Viani de Andrade, Pablo Shimaoka Chagas, Rosane Gomes de Paula Queiróz, Felipe Amstalden Trevisan, Ricardo Santos de Oliveira et al. · 2020 · Scientific Reports
  25. The Eya1 Phosphatase Mediates Shh-Driven Symmetric Cell Division of Cerebellar Granule Cell Precursors
    Daniel J. Merk, Pengcheng Zhou, Samuel M. Cohen, Maria F. Pazyra‐Murphy, Grace H. Hwang, Kristina J. Rehm, Jose Alfaro, Christopher M. Reid, Xuesong Zhao, Eunyoung Park et al. · 2020 · Developmental Neuroscience
  26. Characterization of G-CSF receptor expression in medulloblastoma
    Megan Rose Paul, Yuchen Huo, Andrea Liu, Jacqueline Lesperance, Alexandra Garancher, Robert J. Wechsler‐Reya, Peter E. Zage · 2020 · Neuro-Oncology Advances
  27. Surviving the hunger games: Metabolic reprogramming in medulloblastoma
    Lorenzo Manfreda, Elena Rampazzo, Luca Persano, Giampietro Viola, Roberta Bortolozzi · 2023 · Biochemical Pharmacology
  28. MBMethPred: a computational framework for the accurate classification of childhood medulloblastoma subgroups using data integration and AI-based approaches
    Edris Sharif Rahmani, Ankita Lawarde, Prakash Lingasamy, Sergio Vela Moreno, Andres Salumets, Vijayachitra Modhukur · 2023 · Frontiers in Genetics
  29. PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma
    Devendra Kumar, Stuti Jain, Donald W. Coulter, Shantaram S. Joshi, Nagendra K. Chaturvedi · 2023 · Cancers
  30. Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
    Foteini Tsiami, Chiara Lago, Noemi Pozza, Federica Piccioni, Xuesong Zhao, Fabienne Luelsberg, David E. Root, Luca Tiberi, Marcel Kool, Jens Schittenhelm et al. · 2024 · Acta Neuropathologica Communications
  31. OLIG2 mediates a rare targetable stem cell fate transition in sonic hedgehog medulloblastoma
    Kinjal Desai, Siyi Wanggou, Erika Luis, Heather Whetstone, Chunying Yu, Robert J. Vanner, Hayden J. Selvadurai, Lilian Lee, Jinchu Vijay, Julia E. Jaramillo et al. · 2025 · Nature Communications
  32. Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic marker
    Andrey Korshunov, Konstantin Okonechnikov, Felix Sahm, Marina Vladimirovna Ryzhova, Damian Stichel, Daniel Schrimpf, David R. Ghasemi, Kristian W. Pajtler, Manila Antonelli, Vittoria Donofrio et al. · 2019 · Acta Neuropathologica
  33. Mini‐symposium in medulloblastoma genomics in the modern molecular era
    David W. Ellison · 2020 · Brain Pathology
  34. Medulloblastoma: “Onset of the molecular era”
    Pavan Kumar Dhanyamraju, Trupti Patel, Sinisa Dovat · 2020 · Molecular Biology Reports
  35. An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastoma
    Thomas Albert, Marta Interlandi, Martin Sill, Monika Graf, Natalia Moreno, Kerstin Menck, Astrid Rohlmann, Viktoria Melcher, Sonja Korbanka, Gerd Meyer zu Hörste et al. · 2020 · Neuro-Oncology
  36. Liposome-Imipramine Blue Inhibits Sonic Hedgehog Medulloblastoma In Vivo
    Tobey J. MacDonald, Jingbo Liu, Bing Yu, Anshu Malhotra, Jenny Munson, Jaekeun C. Park, Kenty Wang, Baowei Fei, Ravi V. Bellamkonda, Jack L. Arbiser · 2021 · Cancers
  37. Regulation of Chemosensitivity in Human Medulloblastoma Cells by p53 and the PI3 Kinase Signaling Pathway
    Aisha Naeem, Varsha Harish, Sophie Coste, Erika M. Parasido, Muhammad Umer Choudhry, Lawrence F. Kromer, Chukuemeka Ihemelandu, Emanuel F. Petricoin, Mariaelena Pierobon, Muhammad S. Noon et al. · 2021 · Molecular Cancer Research
  38. Notch signaling and natural killer cell infiltration in tumor tissues underlie medulloblastoma prognosis
    Kung‐Hao Liang, Che‐Chang Chang, Kuo-Sheng Wu, Alice Lin-Tsing Yu, Shian-Ying Sung, Yi‐Yen Lee, Muh‐Lii Liang, Hsin‐Hung Chen, Jun-Jeng Fen, Meng-En Chao et al. · 2021 · Scientific Reports
  39. Role of Precision Medicine in Pediatric Oncology
    Christine Cahaney, Aditi Dhir, Taumoha Ghosh · 2022 · Pediatric Annals
  40. Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline
    Mary Jane Lim-Fat, Maria MacDonald, Sarah Lapointe, Seth Climans, Chantel Cacciotti, Manik Chahal, Sébastien Perreault, Derek S. Tsang, Andrew F. Gao, Stephen S. F. Yip et al. · 2022 · Frontiers in Oncology
  41. Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy
    Yulong Zheng, Qiqi Gao, Xingyun Su, Cheng Xiao, Bo Yu, Shenglin Huang, Yifeng Sun, Sheng Wu, Yixin Wo, Qinghua Xu et al. · 2022 · Cancers
  42. Clinical Applications of Quantitative 3-Dimensional MRI Analysis for Pediatric Embryonal Brain Tumors
    Jared H. Hara, Ashley Wu, Javier E. Villanueva-Meyer, Gilmer Valdés, Vikas Daggubati, Sabine Mueller, Timothy D. Solberg, Steve E. Braunstein, Olivier Morin, David Ronan Raleigh · 2018 · International Journal of Radiation Oncology*Biology*Physics
  43. Medulloblastomas in cerebellopontine angle: Epidemiology, clinical manifestations, imaging features, molecular analysis and surgical outcome
    Haijian Xia, Dong Zhong, Xuedong Wu, Jiong Li, Yaying Yang, Xiaochuan Sun · 2019 · Journal of Clinical Neuroscience
  44. Aberrantly expressed microRNAs and their implications in childhood central nervous system tumors
    Julia Alejandra Pezuk, Karina Bezerra Salomão, Mirella Baroni, Carolina Alves Pereira Corrêa, Lenisa Geron, María Sol Brassesco · 2019 · Cancer and Metastasis Reviews
  45. Involvement of Heparan Sulfate and Heparanase in Neural Development and Pathogenesis of Brain Tumors
    Anqi Xiong, Argyris Spyrou, Karin Forsberg‐Nilsson · 2020 · Advances in experimental medicine and biology
  46. Pediatric Posterior Fossa Medulloblastoma: The Role of Diffusion Imaging in Identifying Molecular Groups
    Nihaal Reddy, David W. Ellison, Bruno Passebon Soares, Kathryn A. Carson, Thierry A.G.M. Huisman, Zoltan J Patay · 2020 · Journal of Neuroimaging
  47. Depletion of kinesin motor KIF20A to target cell fate control suppresses medulloblastoma tumour growth
    Runxiang Qiu, Jun Wu, Brian L. Gudenas, Paul A. Northcott, Robert J. Wechsler‐Reya, Qiang Lü · 2021 · Communications Biology
  48. MiR-592 activates the mTOR kinase, ERK1/ERK2 kinase signaling and imparts neuronal differentiation signature characteristic of Group 4 medulloblastoma
    Raikamal Paul, Purna Bapat, Akash Deogharkar, Sadaf Kazi, Satish Kumar Vishram Singh, Tejpal Gupta, Rakesh Jalali, Sridhar Epari, Aliasgar V. Moiyadi, Prakash M. Shetty et al. · 2021 · Human Molecular Genetics
  49. WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go?
    Shakthivel Mani, Abhishek Chatterjee, Archya Dasgupta, Neelam Vishwanath Shirsat, Sridhar Epari, Girish Chinnaswamy, Tejpal Gupta · 2023 · Oncotarget
  50. PDLIM3 supports hedgehog signaling in medulloblastoma by facilitating cilia formation
    Jie Zhang, Yijun Yang, Xinhua Li, Gen Lin Li, Takuya Mizukami, Yanli Liu, Yuan Wang, Guoqiang Xu, Heinrich Röder, Li Zhang et al. · 2023 · Cell Death and Differentiation
  51. Current status of DNA methylation profiling in neuro-oncology as a diagnostic support tool: A review
    Jyotsna Singh, Saumya Sahu, Trishala Mohan, Swati Mahajan, Mehar Chand Sharma, Chitra Sarkar, Vaishali S. Suri · 2023 · Neuro-Oncology Practice
  52. Management and Long-term Outcomes of Adults With Medulloblastoma
    Bryan J. Neth, Aditya Raghunathan, Sani Haider Kizilbash, Joon H. Uhm, William G. Breen, Derek Richard Johnson, David J. Daniels, Ugur T. Sener, Ivan Darin Carabenciov, Jian Li Campian et al. · 2023 · Neurology
  53. A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing
    Olivier Saulnier, Jamie L. Zagozewski, Lisa Liang, Liam D. Hendrikse, Paul Jerard Layug, Victor Dela Gordon, Kimberly A. Aldinger, Parthiv Haldipur, Stephanie Borlase, Ludivine Coudière-Morrison et al. · 2024 · Nature Cell Biology
  54. Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing
    Niek F. H. N. van Bree, Ann-Sophie Oppelt, Susanne Lindström, Leilei Zhou, Lola Boutin, Beth Coyle, Fredrik J. Swartling, John Inge Johnsen, Lars Bräutigam, Margareta Wilhelm · 2024 · Neuro-Oncology
  55. Granule neuron precursor cell proliferation is regulated by NFIX and intersectin 1 during postnatal cerebellar development
    James Fraser, Alexandra Essebier, Alexander S. Brown, Raul Alfredo Ayala Davila, Ameet S. Sengar, YuShan Tu, Kathleen S. Ensbey, Bryan W. Day, Matthew P. Scott, Richard M. Gronostajski et al. · 2018 · Brain Structure and Function
  56. Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens
    Kee Kiat Yeo, Ashley Margol, Rebekah J. Kennedy, Long T. Hung, Nathan John Robison, Girish Dhall, Shahab Asgharzadeh · 2019 · Journal of Neuro-Oncology
  57. Preclinical Models of Craniospinal Irradiation for Medulloblastoma
    Jennifer L. Stripay, Thomas E. Merchant, Martine F. Roussel, Christopher L. Tinkle · 2020 · Cancers
  58. CLEP: a hybrid data- and knowledge-driven framework for generating patient representations
    Vinay Srinivas Bharadhwaj, Mehdi Ali, Colin J. Birkenbihl, Sarah Mubeen, Jens Lehmann, Martin Hofmann‐Apitius, Charles Tapley Hoyt, Daniel Domingo‐Fernándéz · 2021 · Bioinformatics
  59. Updates on the 2016 World Health Organization Classification of Pediatric Tumors of the Central Nervous System - a systematic review
    Maria Margareta Cosnarovici, Rodica Cosnarovici, Doina Piciu · 2021 · Medicine and Pharmacy Reports
  60. Noncoding RNAs in pediatric brain tumors: Molecular functions and pathological implications
    Shaohuai Chen, Xiangyang Deng, Hansong Sheng, Yuxi Rong, Yanhao Zheng, Yusong Zhang, Jian Jiang Lin · 2021 · Molecular Therapy — Nucleic Acids
  61. Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study
    Alberto Delaidelli, Christopher Dunham, Mariarita Santi, Gian Luca Negri, Joanna Triscott, Olga Zheludkova, Андрей Владимирович Голанов, Marina Ryzhova, Konstantin Okonechnikov, Daniel Schrimpf et al. · 2021 · Clinical Cancer Research
  62. Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups
    Emilia Bevacqua, Jasmin Farshchi, Maria Victoria Niklison-Chirou, Paola Tucci · 2021 · Cancers
  63. Pediatric versus Adult Medulloblastoma: Towards a Definition That Goes beyond Age
    Joseph R. Wooley, Marta Peñas-Prado · 2021 · Cancers
  64. An updated assessment of 43,110 patients enrolled in the Childhood Cancer Research Network: A Children's Oncology Group report
    Austin L. Brown, Pagna Sok, Michael E. Scheurer, Karen R. Rabin, Erin L. Marcotte, Douglas S. Hawkins, Logan G. Spector, Philip J. Lupo · 2022 · Cancer
  65. MiR-212-3p functions as a tumor suppressor gene in group 3 medulloblastoma via targeting nuclear factor I/B (NFIB)
    Naveenkumar Perumal, Ranjana Kumari Kanchan, David Doss, Noah Bastola, Pranita Atri, Ramakanth Chirravuri‐Venkata, Ishwor Thapa, Raghupathy Vengoji, Shailendra Kumar Maurya, David L. Klinkebiel et al. · 2021 · Acta Neuropathologica Communications
  66. Epigenetics and immune cells in medulloblastoma
    Francesca Gorini, Marco Miceli, Pasqualino De Antonellis, Stefano Amente, Massimo Zollo, Veronica Ferrucci · 2023 · Frontiers in Genetics
  67. Genomic and Transcriptomic Analyses Reveals ZNF124 as a Critical Regulator in Highly Aggressive Medulloblastomas
    Zaili Luo, Xinran Dong, Jianzhong Yu, Yong Xia, Kalen Berry, Rohit Rao, Lingli Xu, Ping Xue, Tong Chen, Yifeng Lin et al. · 2021 · Frontiers in Cell and Developmental Biology
  68. Central Nervous System Tumors in Children
    Katherine Clark Pehlivan, Megan Rose Paul, John Ross Crawford · 2021 · Pediatrics in Review
  69. Oncogenic role of cytomegalovirus in medulloblastoma?
    Alejandro M. Hortal, Jeroen F. Vermeulen, Wim Van Hecke, Niels Bovenschen · 2017 · Cancer Letters
  70. Pediatric Patients With SHH Medulloblastoma Fail Differently as Compared With Adults: Possible Implications for Treatment Modifications
    Archya Dasgupta, Tejpal Gupta, Sridhar Epari, Neelam Vishwanath Shirsat, Rahul Krishnatry, Jayant Sastri Goda, Girish Chinnaswamy, Rakesh Jalali · 2019 · Journal of Pediatric Hematology/Oncology
  71. SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma
    Lospinoso Severini, Ludovica, Loricchio, Elena, Navacci, Shirin, Basili, Irene, Alfonsi, Romina, Bernardi, Flavia, Moretti, Marta, Conenna, Marilisa, Cucinotta, Antonino, Coni, Sonia et al. · 2024 · Cell Death & Differentiation
  72. Evolution of Systemic Therapy in Medulloblastoma Including Irradiation-Sparing Approaches
    Naureen Mushtaq, Rahat Ul Ain, Syed Ahmer Hamid, Éric Bouffet · 2023 · Diagnostics
  73. Drivers Underlying Metastasis and Relapse in Medulloblastoma and Targeting Strategies
    Karl O. Holmberg, Anna Borgenvik, Miao Zhao, G Giraud, Fredrik J. Swartling · 2024 · Cancers
  74. The Role of Chronic Inflammation in Pediatric Cancer
    Christine Mella, Panogiotis Tsarouhas, Maximillian Brockwell, Hope C. Ball · 2025 · Cancers
  75. MicroRNA–mRNA expression profiles associated with medulloblastoma subgroup 4
    Sivan Gershanov, Helen Toledano, Shalom D. Michowiz, Orit Barinfeld, Albert Pinhasov, Nitza Goldenberg‐Cohen, Mali Salmon‐Divon · 2018 · Cancer Management and Research
  76. Medulloblastoma: Challenges and advances in treatment and research
    Vahan Martirosian, Josh Neman · 2018 · Cancer Reports
  77. CNS Penetration of Cyclophosphamide and Metabolites in Mice Bearing Group 3 Medulloblastoma and Non-Tumor Bearing Mice
    Clinton F. Stewart, Olivia Campagne, Abigail Davis, Bo Zhong, Sreenath Nandakumar Nair, Victoria Haberman, Yogesh T. Patel, Laura J. Janke, Martine F. Roussel · 2019 · Journal of Pharmacy & Pharmaceutical Sciences
  78. Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth
    Cecilia H. Dyberg, Teodora Andonova, Thale Kristin Olsen, Bertha A. Brodin, Marcel Kool, Per Kogner, John Inge Johnsen, Malin Wickström · 2019 · Cancers
  79. An ABC Transporter Drives Medulloblastoma Pathogenesis by Regulating Sonic Hedgehog Signaling
    Juwina Wijaya, Baohan Thi Vo, Jingjing Liu, Beisi Xu, Gang Wu, Yao Wang, Junmin Peng, Jin Zhang, Laura J. Janke, Brent A. Orr et al. · 2020 · Cancer Research
  80. Construction and Validation of a 13-Gene Signature for Prognosis Prediction in Medulloblastoma
    Chang Li, Han Zou, Zujian Xiong, Yi Xiong, Danielle F. Miyagishima, Siyi Wanggou, Xuejun Li · 2020 · Frontiers in Genetics
  81. Update on Pediatric Brain Tumors: the Molecular Era and Neuro-immunologic Beginnings
    Elizabeth S. Duke, Roger J. Packer · 2020 · Current Neurology and Neuroscience Reports
  82. A circular RNA from NFIX facilitates oxidative stress-induced H9c2 cells apoptosis
    Xianglun Cui, Yanhan Dong, Mingyu Li, Xuekang Wang, Meiqing Jiang, Weiwei Yang, Gege Liu, Shuqi Sun, Wenhua Xu · 2020 · In Vitro Cellular & Developmental Biology - Animal
  83. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
    Laura A. Genovesi, Amanda Millar, Elissa Tolson, Matthew Singleton, Emily Hassall, Marija Kojic, Caterina Brighi, Emily J. Girard, Clara Andradas, Mani Kuchibhotla et al. · 2021 · Genome Medicine
  84. Epigenetic mechanisms in paediatric brain tumours: regulators lose control
    Sara Badodi, Silvia Marino · 2022 · Biochemical Society Transactions
  85. Spatial proteomics finds CD155 and Endophilin-A1 as mediators of growth and invasion in medulloblastoma
    Charles Capdeville, Linda A. Russo, David Pentón, Jessica Migliavacca, Milica Zecevic, Alexandre Gries, Stephan C. F. Neuhauss, Michael Andreas Grotzer, Martin Baumgartner · 2022 · Life Science Alliance
  86. Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic strategies
    Qiyue Wang, Xiaofei Xin, Qihao Dai, Mengjuan Sun, Jinhua Chen, Ebrahim Mostafavi, Yan Shen, Xueming Li · 2023 · Pharmacology & Therapeutics
  87. Radiogenomics of medulloblastoma: imaging surrogates of molecular biology
    Archya Dasgupta, Tejpal Gupta · 2018 · Journal of Translational Genetics and Genomics
  88. Molecular characterization of Wnt pathway and function of β-catenin overexpression in medulloblastoma cell lines
    Lenisa Geron, Karina Bezerra Salomão, Kleiton Silva Borges, Augusto Faria Andrade, Carolina Alves Pereira Corrêa, Carlos Alberto Scrideli, Luíz Gonzaga Tone · 2018 · Cytotechnology
  89. Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profiles
    Andrey Korshunov, Felix Sahm, Konstantin Okonechnikov, Marina Vladimirovna Ryzhova, Damian Stichel, Daniel Schrimpf, Belén Casalini, Philipp Sievers, Jochen Meyer, Olga Zheludkova et al. · 2019 · Acta Neuropathologica
  90. Imaging Characteristics of Wingless Pathway Subgroup Medulloblastomas: Results from the German HIT/SIOP-Trial Cohort
    Annika Stock, Martin Mynarek, Torsten Pietsch, Stefan Michael Pfister, S.C. Clifford, Tobias Goschzik, Dominik Sturm, Ed C. Schwalbe, Debbie Hicks, Stefan Rutkowski et al. · 2019 · American Journal of Neuroradiology
  91. Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients
    Maura Massimino, Marie Pierre Sunyach, Francesco Barretta, Lorenza Gandola, Anna Garegnani, Emilia Pecori, Filippo Spreafico, Alice Bonneville-Levard, David Meyronet, C. Mottolèse et al. · 2020 · Journal of Neuro-Oncology
  92. Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma Workshop
    Marta Peñas-Prado, Brett James Theeler, Brittany Cordeiro, Ira J. Dunkel, Peter Hau, Anita Mahajan, Giles W Robinson, Nicole E. Willmarth, Orwa Aboud, Kenneth Aldape et al. · 2020 · Neuro-Oncology Advances
  93. The 100 Most Influential Publications on Medulloblastoma: Areas of Past, Current, and Future Focus
    Nolan James Brown, Bayard R. Wilson, Shane Shahrestani, Elliot H. Choi, Brian V. Lien, Anushka Paladugu, Katelynn Tran, Seth C. Ransom, Ali R. Tafreshi, Ryan C. Ransom et al. · 2020 · World Neurosurgery
  94. From sorting to sequencing in the molecular era: the evolution of the cancer stem cell model in medulloblastoma
    Tamra E. Werbowetski‐Ogilvie · 2021 · FEBS Journal
  95. Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells
    Jia Wei, Ling Ma, Chenglong Li, Christopher R. Pierson, Jonathan L. Finlay, Jiayuh Lin · 2018 · Current Cancer Drug Targets
  96. Targeting AKT and CK2 represents a novel therapeutic strategy for SMO constitutive activation‐driven medulloblastoma
    Yueliang Yao, Yanxia Wang, Fei‐Cheng Yang, Chuan Wang, Min Mao, Qu‐Jing Gai, Jiang He, Yan Qin, Xiao‐Xue Yao, Xi Lan et al. · 2022 · CNS Neuroscience & Therapeutics
  97. Molecular subgrouping of medulloblastoma in pediatric population using the NanoString assay and comparison with immunohistochemistry methods
    Joo Whan Kim, Sung‐Hye Park, Seung Ah Choi, Seung‐Ki Kim, Eun Jung Koh, Jae‐Kyung Won, Sun Mo Nam, Ji Hoon Phi · 2022 · BMC Cancer
  98. A Radiologist’s Guide to the 2021 WHO Central Nervous System Tumor Classification: Part 2—Newly Described and Revised Tumor Types
    Julie B. Guerin, Timothy J. Kaufmann, Laurence J. Eckel, Jonathan M. Morris, Rachael A. Vaubel, Caterina Giannini, Derek Richard Johnson · 2023 · Radiology
  99. Similarity network fusion to identify phenotypes of small-for-gestational-age fetuses
    Jezid Miranda, Cristina Paulés, Guillaume G. Noell, L. Youssef, Ángel José Paternina-Caicedo, F. Crovetto, Nicolau Cañellas, Maria Luisa García‐Martín, Núria Amigó, E. Eixarch et al. · 2023 · iScience
  100. ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip
    John J. Y. Lee, Ran Tao, Zhen You, Parthiv Haldipur, Anders Wilder Erickson, Hamza Farooq, Liam D. Hendriske, Namal Abeysundara, Cory M. Richman, Evan Y. Wang et al. · 2025 · Nature Genetics